Ex vivo gene therapy using autologous dermal fibroblasts expressing hLMP3 for rat mandibular bone regeneration

Head and Neck

Volumn 32, Issue 3, 2010, Pages 310-318

  Parrilla, Claudio ^a   Lattanzi, Wanda ^a   Fetoni, Anna Rita ^a   Bussu, Francesco ^a   Pola, Enrico ^a   Paludetti, Gaetano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autologous dermal fibroblast; Ex vivo gene therapy; LMP 3; Mandibular bone defect; Osteogenesis

Indexed keywords

ADENOVIRUS VECTOR; LIM MINERALIZATION PROTEIN 3; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE REGENERATION; CONTROLLED STUDY; EX VIVO STUDY; GENE THERAPY; HISTOLOGY; HUMAN; JAW DISEASE; MANDIBULAR BONE REGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SKIN FIBROBLAST; THREE DIMENSIONAL IMAGING; WISTAR RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; COLLAGEN; DERMIS; DURAPATITE; FIBROBLASTS; GENE THERAPY; GUIDED TISSUE REGENERATION; HOMEODOMAIN PROTEINS; MANDIBLE; OSTEOGENESIS; RATS; RATS, WISTAR; TISSUE SCAFFOLDS; TRANSDUCTION, GENETIC;

EID: 76249087915     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21185     Document Type: Article

References (37)

1. Albertson KS, Medoff RJ, Mitsunaga MM. The use of periosteally vascularized autografts to augment the fixation of large segmental allografts. Clin Orthop Rel Res 1991;269:113-119.
2. Enneking WF, Mindell ER. Observations on massive retrieved human allografts. J Bone Joint Surg Am 1999; 73:1123-1142.
3. Borden M, Attawia M, Khan Y, Amin S, Laurencin CT. Tissue engineered bone formation in vivo using a novel sintered polymeric microsphere matrix. J Bone Joint Surg Br 2004;86:1200-1208.
4. CooK SD, Wolfe MW, Salkeld SL, Rueger DCl. Effect of recombinant human osteogenic protein 1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 1995;77:734-750.
5. Lattanzi W, Pola E, Pecorini G, Logroscino CA, Robbins PD. Gene therapy for in vivo bone formation: recent advances. Eur Rev Med Pharmacol Sci 2005;9:167-174.
6. Einhorn TA. Clinical applications of recombinant human BMPs. Early experience and future development. J Bone Joint Surg Am 2003;85(A Suppl 3):82-88.
7. Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 2000;142:9-21.
8. Blum JS, Barry MA, Mikos AG. Bone regeneration through transplantation of genetically modified cells. Clin Plast Surg 2003;30:611-620.
9. Chang SC, Chuang HL, Chen YR, et al. Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Ther 2003;10:2013-2019.
10. Cheng H, Jiang W, Philips FM, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003;85-A:1544-1552.
11. Moutsatsos IK, Turgeman G, Zhou S, et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 2001;3:449-461.
12. Boden SD, Liu Y, Hair GA, et al. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Endocrinology 1998;139:5125-5134.
13. Liu Y, Hair GA, Boden SD, et al. Overexpressed LIM mineralization proteins do not require LIM domains to induce bone. J Bone Miner Res 2002;17:406-414.
14. Minamide A, Boden SD, Viggeswarapu M, et al. Mechanism of bone formation with gene transfer of the cDNA encoding for the intracellular protein LMP-1. J Bone Joint Surg Am 2003;85-A:1030-1039.
15. Boden SD, Titus L, Hair G, et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 1998;23:2486-2492.
16. Boden SD. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation. Tissue Eng 2000;6:383-399.
17. Viggeswarapu M, Boden SD, Liu Y, et al. Adenoviral delivery of LIM mineralization protein-1 induces newbone formation in vitro and in vivo. J Bone Joint Surg Am 2001;83-A:364-376.
18. Pola E, Gao W, Zhou Y, et al. Efficient bone formation by gene transfer of human LIM mineralization protein-3 (LMP-3). Gene Ther 2004;11:683-693.
19. Lattanzi W, Parrilla C, Fetoni A, et al. Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models. Gene Ther 2008;15:1330-1343.
20. Landi E, Logroscino G, Proietti L, Tampieri A, Sandri M, Sprio S. Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour. J Mater Sci Mater Med 2008;19:239-247.
21. Franceschi RT, Wang D, Krebsbach PH, Rutherfor RB. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 2000;78:476-486.
22. Schilephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002; 31;469-484.
23. Schliephake H, Knebel JW, Aufderheide M, Tauscher M. Use of cultivated osteoprogenitor cells to increase bone formation in segmental mandibular defects: an experimental pilot study in sheep. Int J Oral Maxillofac Surg 2001;30:531-537.
24. Abukawa H, Shin M, Williams WB, Vacanti JP, Kaban LB, Troulis MJ. Reconstruction of mandibular defects with autologous tissue-engineered bone. J Oral Maxillofac Surg 2004;62:601-606.
25. Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cellexpressed VEFG and bone morphogenetic protein-4. J Clin Invest 2002;110:751-759.
26. Sugiyama O, An DS, Kung SP, et al. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 2005;11:390-398.
27. Toriumi DM, O'Grady K, Horlbeck DM, Desai D, Turek TJ, Wozney J. Mandibular reconstruction using bone morphogenetic protein 2: long-term follow up in a canine model. Laryngoscope 1999;109:1481-1489.
28. Li JZ, Dunford B, Holman D, et al. Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenoviruses. Mol Ther 2003;8:822-829.
29. Franceschi RT, Yang S, Rutherford RB, Krebsbach PH, Zhao M, Wang D. Gene therapy approaches for bone regeneration. Cells Tissues Organs 2004;176:95-108.
30. Zhu W, Rawlins BA, Borchie-Adjei O, et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhance osteoblastic differentation and spine fusion in a rodent model. J Bone Miner Res 2004;19:2021-2032.
31. Zhao M, Zhao Z, Koh J-T, Jin T, Franceschi RT. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4 and 7. J Cell Biochem 2005; 95:1-16.
32. Zheng H, Guo Z, Ma Q, Jia H, Dang G. Cbfa I/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcif Tissue Int 2004;74:194-203.
33. Baltzer AW, Lattermann C, Whalen JD, et al. Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clin Orthop Relat Res 2000;379(Suppl):S120-S125.
34. Gugala Z, Olmsted-Davis EA, Gannon FH, Lindsey RW, Davis AR. Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Gene Ther 2003;10:1289-1296.
35. Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003;5:362-369.
36. Shen HC, Peng H, Usas A, et al. Ex vivo gene therapyinduced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone 2004;34:982-992.
37. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-celllike state. Nature 2007;448:318-324.